These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11699426)

  • 21. Relapse of Hodgkin's disease after 10 years of complete remission: case report.
    Mwanda OW; Othieno-Abinya N
    East Afr Med J; 1998 Mar; 75(3):192-4. PubMed ID: 9640822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapy for advanced Hodgkin's disease.
    Gupta T; Sanghavi V; Laskar S
    N Engl J Med; 2003 Sep; 349(12):1187-8; author reply 1187-8. PubMed ID: 13679537
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hodgkin's disease and infection with human immunodeficiency virus].
    Auguet Quintillá T; Pedro-Botet Montoya J; Planas Domingo J; Gallén Castillo M
    Sangre (Barc); 1992 Feb; 37(1):39-41. PubMed ID: 1374934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease].
    Suon SZ
    Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):117-120, contd. PubMed ID: 2580675
    [No Abstract]   [Full Text] [Related]  

  • 25. [Controversy regarding the treatment of Hodgkin's disease].
    Balwierz W; Armata J
    Pol Tyg Lek; 1989 Apr; 44(14):315-9. PubMed ID: 2482966
    [No Abstract]   [Full Text] [Related]  

  • 26. [Relapse of Hodgkin disease after 17 years of complete remission. A case report].
    Osorio G; Caglevic C
    Rev Med Chil; 2003 Feb; 131(2):197-9. PubMed ID: 12708259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease.
    Loeffler M; Diehl V; Pfreundschuh M; Rühl U; Hasenclever D; Nisters-Backes H; Sieber M; Tesch H; Franklin J; Geilen W; Bartels H; Cartoni C; Dölken G; Enzian J; Fuchs R; Gassmann W; Gerhartz H; Hagen-Aukamp U; Hiller E; Hinkelbein H; Hinterberger W; Kirchner H; Koch P; Krüger B; Schwarze EW
    J Clin Oncol; 1997 Jun; 15(6):2275-87. PubMed ID: 9196141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Limphomatous meningitis as recurrence site in Hodgkin's disease].
    Greco M; Valsecchi M; Niccodemi C; Presas J; Corrado C; Winkel M
    Medicina (B Aires); 2006; 66(4):332-4. PubMed ID: 16977969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
    Diehl V; Franklin J; Pfreundschuh M; Lathan B; Paulus U; Hasenclever D; Tesch H; Herrmann R; Dörken B; Müller-Hermelink HK; Dühmke E; Loeffler M;
    N Engl J Med; 2003 Jun; 348(24):2386-95. PubMed ID: 12802024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Constine LS
    J Clin Oncol; 1998 Mar; 16(3):1235. PubMed ID: 9508214
    [No Abstract]   [Full Text] [Related]  

  • 31. Henoch-Schönlein purpura associated with segmental and focal proliferative glomerulonephritis in a patient with Hodgkin's disease.
    Blanco P; Denisi R; Rispal P; Deminière C; Pellegrin JL; Leng B; Aparicio M
    Nephrol Dial Transplant; 1999 Jan; 14(1):179-80. PubMed ID: 10052501
    [No Abstract]   [Full Text] [Related]  

  • 32. [Laparotomy with splenectomy in the evaluation of the results of cytostatic treatment of patients with advanced Hodgkin's disease].
    Płuzańska A; Berner J; Kowalczyński M; Dowgier-Witczak I; Chmielowska E; Woźniak L
    Pol Arch Med Wewn; 1986 May; 75(5):344-50. PubMed ID: 2431397
    [No Abstract]   [Full Text] [Related]  

  • 33. Glomerulonephritis preceding late relapse of Hodgkin's disease.
    Lynn WA; Marcus RE
    Postgrad Med J; 1988 May; 64(751):395-7. PubMed ID: 3200784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
    Comella P; Abate G; Fiore M; Di Finizio G; Frezza P; Scoppa G; Anania C; Coucourde F; Zarrilli D
    J Chemother; 1989 Jul; 1(4 Suppl):1254-6. PubMed ID: 16312855
    [No Abstract]   [Full Text] [Related]  

  • 35. MOPP versus ABVD and low-dose versus high-dose irradiation in Hodgkin's disease at intermediate and advanced stages: analysis of a meta-analysis by clinicians.
    Andrieu JM; Yilmaz U; Colonna P
    J Clin Oncol; 1999 Feb; 17(2):730-4. PubMed ID: 10080622
    [No Abstract]   [Full Text] [Related]  

  • 36. ABMT recommended for relapsed Hodgkin's disease, but better overall survival not yet proved.
    Oncology (Williston Park); 1996 Apr; 10(4):593-4. PubMed ID: 8723294
    [No Abstract]   [Full Text] [Related]  

  • 37. [Primary treatment of advanced Hodgkin's disease].
    Illés A; Udvardy M; Molnár Z
    Orv Hetil; 2005 Jan; 146(5):195-202. PubMed ID: 15773586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP) before radiotherapy in localized stages of Hodgkin's disease. Phase II trials].
    Zittoun R; Eghbali H; Audebert A; Rojouan J; David B; Blanc CM; Hoerni B; Debray J
    Bull Cancer; 1987; 74(2):151-7. PubMed ID: 2440504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rescue treatment in Hodgkin's disease].
    Zori Comba A; Koziner B
    Sangre (Barc); 1987; 32(1):67-76. PubMed ID: 2438788
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
    Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS
    Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.